NCT00749944 - Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions

Smoking Cessation

Interventions

DRUG

varenicline

1 mg tablets twice daily by mouth (after one week of uptitration: 0.5mg once daily for three days, 0.5mg twice daily for four days)

DRUG

placebo

1 mg tablets twice daily by mouth (after one week of uptitration: 0.5mg once daily for three days, 0.5mg twice daily for four days)

Trial Locations (2)

Pfizer Investigational Site, San Antonio

Pfizer Investigational Site, Austin